1. Home
  2. ANNX vs SCHL Comparison

ANNX vs SCHL Comparison

Compare ANNX & SCHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$5.79

Market Cap

972.5M

Sector

Health Care

ML Signal

HOLD

Logo Scholastic Corporation

SCHL

Scholastic Corporation

HOLD

Current Price

$40.51

Market Cap

842.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANNX
SCHL
Founded
2011
1920
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Books
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
972.5M
842.4M
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
ANNX
SCHL
Price
$5.79
$40.51
Analyst Decision
Strong Buy
Hold
Analyst Count
6
1
Target Price
$16.50
$40.00
AVG Volume (30 Days)
2.2M
733.4K
Earning Date
05-11-2026
03-19-2026
Dividend Yield
N/A
1.99%
EPS Growth
N/A
N/A
EPS
N/A
1.87
Revenue
N/A
$1,487,100,000.00
Revenue This Year
N/A
$1.88
Revenue Next Year
$16,320.74
$4.05
P/E Ratio
N/A
$21.70
Revenue Growth
N/A
N/A
52 Week Low
$1.60
$16.78
52 Week High
$7.18
$43.39

Technical Indicators

Market Signals
Indicator
ANNX
SCHL
Relative Strength Index (RSI) 47.71 58.00
Support Level $4.79 $27.31
Resistance Level $6.56 $43.39
Average True Range (ATR) 0.29 1.52
MACD -0.06 -0.10
Stochastic Oscillator 8.43 49.48

Price Performance

Historical Comparison
ANNX
SCHL

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About SCHL Scholastic Corporation

Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.

Share on Social Networks: